COVID Data Initiative (INCODA)

  • Funded by Netherlands Organisation for Health Research and Development (ZonMW)
  • Total publications:0 publications

Grant number: 1.043E+13

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2022
  • Funder

    Netherlands Organisation for Health Research and Development (ZonMW)
  • Principal Investigator

    N. Breedveld
  • Research Location

    N/A
  • Lead Research Institution

    Amsterdam Health and Technology Institute
  • Research Priority Alignment

    N/A
  • Research Category

    Epidemiological studies

  • Research Subcategory

    Disease susceptibility

  • Special Interest Tags

    Data Management and Data Sharing

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Within the project, a dataset has been built of almost all residents of the Netherlands, linked to the GGD test results and COVID-19 related hospital and ICU admissions and deaths. This combined dataset was then used to examine both the risk of infection and the risk of hospital admission, ICU admission and/or death. All results show that socio-demographic factors, such as income, age and migration background, strongly influence both the risk of a SARS-Cov-2 infection and the risk of a serious course of COVID-19. It also becomes clear that it may differ per city or safety region which group has the highest risk of infection. There is a dashboard with the available (anonymous) data developed which makes it possible for everyone to get a detailed picture of which groups tested where and at what time, tested positive for the coronavirus, who was in hospital and who died as a result of the virus. The objectives of INCODA are: 1. Identify groups at high risk for a COVID-19 infection with a serious course 2. Investigate whether the combination of medical characteristics and clinical parameters with geographical, demographic and socio-economic characteristics is valuable and can be used for, among other things, secondary prevention measures and choosing treatment methods INCODA does this by: • combining clinical and ICU admission data of COVID-19 patients with CBS data • identifying risk groups based on a multivariable profile and developing prediction models for the risk of a serious course of COVID-19 • investigating possible interventions